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Synthetic peroxovanadium compounds are a new class of potent inhibitors of protein phosphotyrosine phosphatases. These
compounds exhibit insulin-like activity both in vitro and in experimental animals. However, the molecular mechanism
by which these compounds exert their biological effect is not well de®ned. We demonstrate here that several of these
compounds induce Xenopus oocyte maturation in vitro, as indicated by germinal vesicle breakdown. Using one of these
compounds for further studies, we show that the induction is dose-dependent and is accompanied by activation of matura-
tion promoting factor as well as activation of Xenopus MAP kinase. Like insulin, bpV(pic) causes an acute accumulation of
PI(3,4,5)P3 (phosphotidylinositol-3,4,5-trisphosphate), a product of PI 3-kinase. More importantly, bpV(pic)-induced oocyte
maturation was abolished by microinjection of a neutralizing monoclonal anti-insulin receptor antibody (17A3) into oocytes
or preincubation of oocytes with a PI 3-kinase inhibitor (wortmannin). These results suggest that bpV(pic) acts upstream
of the Xenopus IGF-1 receptor in the induction of meiotic maturation, presumably by neutralizing an inhibitory protein
tyrosine phosphatase(s) that may regulate the receptor. Finally, using an oocyte±follicle cell complex that responded to
human chorionic gonadotropin (hCG) to undergo GVBD, we showed that injection of 17A3 anti-insulin receptor antibody
into oocytes did not affect hCG-induced oocyte maturation. q 1996 Academic Press, Inc.
INTRODUCTION rosine phosphatase (PTPase)2 activity. Speci®cally, these
compounds stimulate tyrosine (auto)phosphorylation of in-
sulin receptor (IR) in the absence of the ligand (Kadota et
Vanadate, a commonly used inhibitor of protein tyrosine al., 1987; Fantus et al., 1989; Heffetz et al., 1990). However,
phosphatases, has long been recognized as having insulin- it remains unclear whether vanadate (or peroxovanadate)-
like effects both in vitro and in experimental animals (see induced autophosphorylation of IR is responsible for their
Shechter, 1990 for a review). More recent studies have indi- insulin-like activity in cells.
cated that a combination of vanadate and H2O2, which pro- Posner et al. (1994) have recently synthesized a group
duces peroxovanadate, is an even more potent insulin of peroxovanadium compounds with a common structure
mimic (Kadota et al. 1987a, 1987b; Lonnroth et al., 1993). containing a central vanadium atom, an oxo group (O20),
When incubated with cultured cells or injected into ani- one or two peroxo groups (O202 ) and an ancillary ligand.
mals, vanadate or peroxovanadate stimulates protein tyro-
sine phosphorylation (Hadari et al. 1993; Kadota et al.,
1987a, 1987b; Fantus, et al., 19089; Heffetz et al., 1990; 2 Abbreviations used: IR, insulin receptor; IGF-1, insulin-like
growth factor 1; GVBD, germinal vesicle breakdown; PMSG, preg-Shisheva et al., 1993), presumably by inhibiting protein ty-
nant mare serum gonadotropin; PTPase, protein tyrosine phospha-
tase; bpV(pic), a peroxovanadium compound with the chemical for-
mula K2[VO(O2)2pic]rH2O where pic stands for pyridine-2-carbox-
ylic acid; SH2, Src homology 2; OR2, the basic oocyte incubation1 To whom correspondence should be addressed at Loeb Medical
Research Institute, Ottawa Civic Hospital, 1053 Carling Avenue, medium used in this study; MPF, maturation promoting factor; PI,




Copyright q 1996 by Academic Press, Inc.
All rights of reproduction in any form reserved.
/ 6x0c$$8187 04-15-96 20:00:01 dba Dev Bio
339A Peroxovanadium Compound Induces Xenopus Oocyte Maturation
for 2.5±3 hr), oocytes were rinsed several times with OR2. TheThese compounds, unlike their predecessor peroxovana-
rinsed oocytes were incubated for an additional 30±60 min withdate, are metabolically stable and hence can be used in long-
gentle shaking. This latter incubation helped remove partially sepa-term cell culture experiments or in intact animals. Indeed,
rated follicular cells from the oocytes. Stage VI oocytes were indi-these compounds exhibit very potent insulin-like activities
vidually selected according to Dumont (1971).including lowering blood glucose level (following intrajugu-
To isolate complexes containing oocytes and the surrounding
lar injection in rats), activating autophosphorylation of IR, follicle cells (for experiments described in Table 2), we simply per-
and inhibiting dephosphorylation of autophosphorylated IR formed manual ``defolliculation'' according to Smith et al. (1991)
(Posner et al., 1994). using watchmaker's forceps. These manually defolliculated oocytes
To evaluate the insulin-like activity of these compounds (containing follicle cells) were incubated in OR2 containing com-
mercial hCG (Sigma).further and to examine their cellular target(s), we have em-
Injection of stage VI Xenopus oocytes was carried out using Atto-ployed Xenopus oocytes as a model system. Fully grown
cyte's Xenopus Work Station. Between 34 and 68 nl of solution(stage VI) Xenopus oocytes undergo meiotic maturation
was injected into each individual oocyte. Injected oocytes were(germinal vesicle breakdown or GVBD) in vitro when stimu-
incubated in appropriate media for 1±2 hr to allow protein diffusionlated with insulin or insulin-like growth factor-1 (IGF-1)
before hormonal treatment.(El-Etr et al., 1979; Maller and Koontz, 1981). The induction
We used 24-well tissue culture plates for all the oocyte matura-
of GVBD by insulin or IGF-1 is apparently mediated by an tion assays. Usually, 1±2 ml of buffers were used for each incu-
endogenous Xenopus IGF-1 receptor (Morgan et al., 1986; bation. Progesterone (®nal concentration 10 mM) stimulation of
Cicirelli et al., 1990; Tonks et al., 1990; Chuang et al., 1993) oocytes was carried out in OR2. To ensure that oocytes respond
and can be blocked by a neutralizing anti-insulin receptor maximally to insulin, we incubated oocytes with insulin (1 mM) in
K/-free OR2 (82.50 mM NaCl, 2.5 mM, 1 mM CaCl2, 1 mM MgCl2,antibody (17A3) (Morgan et al., 1986) or a neutralizing anti-
1 mM Na2HPO4, 5 mM Hepes, pH 7.8) (Cicirelli et al., 1990; TonksRas antibody (Y13-259) (Deshpande and Kung, 1987). We
et al., 1990). Elimination of K/ ion from OR2 had no effect onhave recently demonstrated that insulin also stimulates
oocyte viability nor did it induce or inhibit oocyte maturation byproduction of 3-phosphorylated phosphoinositides [PI(3,4)P2
itself (data not shown). Peroxovanadium compounds were weighedand PI(3,4,5)P3], products of PI 3-kinase, in Xenopus oocytes just prior to use and were dissolved in 10 mM phosphate buffer,and that a PI 3-kinase inhibitor (wortmannin) inhibits insu-
pH 7.5, as a 100 mM stock solution. Appropriate amounts of these
lin-induced oocyte maturation (Liu et al., 1995). In the cur- stock solutions were added to oocytes in OR2 without K/ ion.
rent study we have analyzed the insulin-mimetic effect of When wortmannin (KAMIYA, Thousand Oaks, CA) was used, the
a peroxovanadium compound on Xenopus oocyte GVBD antibiotic (dissolved as 1000-fold stock solutions in dimethylsulf-
and on accumulation of 3-phosphorylated phosphoinosi- oxide) was added to oocytes. Following a 10-min incubation, the
oocytes were rinsed two to three times by transferring them totides. We have also analyzed the ability of two inhibitors
successive wells containing wortmannin-free OR2. To assay for(17A3 and wortmannin) on these insulin-mimetic effects.
meiotic maturation, the oocytes were incubated with the various
agonists overnight at 187C. GVBD was determined by the appear-
ance of a white spot at the center of the animal hemisphere andMATERIALS AND METHODS
con®rmed, when questionable, by bisecting the oocytes following
®xation in 5% trichloroacetic acid and observing the presence
Peroxovanadium Compounds (GVBD negative) or absence (GVBD positive) of a germinal vesicle.
All three peroxovanadium compounds were generous gifts of
Barry Posner and Alan Shaver (Posner et al., 1994). They are
Oocyte MPF Extract and Oocyte Cell LysateK2[VO(O2)2pic]rH2O or bpV(pic), where pic stands for pyridine-2-
carboxylic acid, K[VO(O2)2phen]r3H2O or bpV(phen), where phen MPF extracts were prepared according to Lohka and Maller (1985)
stands for 1,10-phenanthroline, and NH4[VO(C2)(2,6-pdc)H2O]rH2O as described below. GVBD positive (or control) oocytes (about 50)
or mpV(2,6-pdc), where 2,6-pdc stands for pyridine-2,6-dicarboxylic
were quickly rinsed twice with 1 ml MPF extraction buffer (20 mM
acid dianion.
Hepes, pH 7.5, 80 mM b-glycerolphosphate, 15 mM MgCl2, 20 mM
EGTA, 1 mM DTT, 0.3 mM PMSF, 3 mg/ml leupeptin). Excess
buffer was aspirated off until no liquid remained on top of theAnimal and Oocyte Manipulation
oocytes. The oocytes which were equilibrated with MPF extraction
buffer were centrifuged at 14,000g for 20 min. The middle layer,Sexually mature and oocyte-positive Xenopus laevis females
were purchased from NASCO and maintained according to local which represented the cytoplasm of oocytes (and hence contained
MPF), was then carefully transferred to a new Eppendorf tube andanimal care guidelines. The animals were injected with pregnant
mare serum gonadotropin (PMSG, Sigma, 50 IU/animal) 3 days stored at 0707C until use. The MPF extract was clari®ed by centrif-
ugation just before each microinjection.prior to oocyte retrieval. A fragment of ovary was removed surgi-
cally under hypothermia. The ovarian tissue was incubated at 187C Oocytes were lysed by forcing them through pipette tips in PBS
lysis buffer (10 mM sodium phosphate, pH 7.5, 150 mM NaCl, 1%with gentle shaking, in oocyte incubation medium OR2 (82.50 mM
NaCl, 2.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, Triton X-100, 10 mg/ml each of leupeptin and aprotinin, 1 mM
phenylmethylsulfonate, and 1 mM sodium orthovanadate). We usu-5 mM Hepes, pH 7.8) containing 2 mg/ml collagenase (Sigma, type
I) but without Ca2/ (Ca2/-free OR2). Defolliculation of oocytes was ally used 10 ml lysis buffer per oocyte. The homogenate was centri-
fuged in an Eppendorf centrifuge for 15 min at 47C. Under thesemonitored by periodically examining a few oocytes under a dis-
secting microscope. Following the collagenase treatment (usually conditions, the yolk protein (vitellogenin) was not solubilized and
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was discarded as a pellet. The cell lysates, which were usually following overnight incubation. All three compounds in-
clouded due to the presence of lipids, were suitable for immunopre- duced GVBD in a dose-dependent manner, with bpV(pic)
cipitation and Western blotting. being the most potent (Fig. 1A). We therefore chose bpV(pic)
for the following experiments. A more detailed dose re-
sponse experiment demonstrated that bpV(pic) was effectivePartial Puri®cation of Xenopus IGF-1 Receptor by within a very narrow range with an IC50 (concentration thatWheat Germ Agglutinin (WGA) Sepharose induces 50% of the treated oocyte to undergo GVBD) ofChromatography 0.25 mM (Fig. 1B). Higher concentrations (greater than 1
mM) of bpV(pic) were toxic in prolonged incubation as indi-Partial puri®cation of Xenopus IGF-1 receptor by WGA Sepharose
was carried out according to Janicot et al. (1989) with slight modi- cated by oocyte decoloring and disintegration (not shown).
®cation. Brie¯y, oocytes were lysed in PBS lysis buffer as described Activation of two protein kinases, maturation promoting
above. Following clari®cation by centrifugation, WGA Sepharose factor (MPF) and Xenopus MAP kinase, is associated with
was added and the mixture was incubated at 47C for 3±4 hr. The progesterone-induced as well as insulin-induced Xenopus
Sepharose beads were washed three times with 50 mM Hepes (pH oocyte maturation. To determine whether bpV(pic)-induced
7.5), 1 mM EDTA, 0.5 M NaCl, 0.1% Triton X-100, 1 mM phenyl-
GVBD had the same characteristics, we examine their activ-methylsulfonyl ¯uoride, 10 mg per milliliter each of leupeptin and
ities in bpV(pic)-treated oocytes. Figure 2A shows that a cellaprotinin, and 1 mM sodium orthovanadate followed by rinsing
extract (see ``MPF extract'' under Materials and Methods)twice with the same buffer (at pH 6.9) minus NaCl and sodium
prepared from GVBD-positive oocytes [following overnightorthovanadate. Xenopus IGF-1 receptor was eluted by 50 mM
incubation with bpV(pic)] was capable of inducing GVBDHepes, pH 7.6, 0.1% Triton X-100, 0.3 M N-acetyl-D-glucosamine
(elution buffer). when injected into new stage VI Xenopus oocytes. These
results indicate that the cytoplasm of bpV(pic)-treated oo-
cytes, like that of progesterone-treated or insulin-treated
Autophosphorylation of Xenopus IGF-1 Receptor oocytes, contained active MPF. In contrast, the cytoplasm
of untreated oocytes (which did not undergo GVBD) did notA partially puri®ed receptor preparation (from 100 oocytes) was
contain active MPF. Activation of Xenopus MAP kinasesplit into six aliquots. The aliquots were preincubated at room
was assayed by a characteristic shift in its migration intemperature for 60 min in elution buffer (see above) or elution
buffer containing 17A3 or nonspeci®c mouse IgG. Samples were SDS±PAGE (slower-migrating form representing the active
then supplemented with kinase buffer (50 mM Hepes, pH 6.9, 1 XMAPK), indicative of phosphorylation on tyrosine and
mM EDTA, 0.1% Triton X-100) and, where indicated, insulin or threonine (Posada and Cooper, 1992). Figure 2B shows that,
IGF-1. The mixtures were incubated at room temperature for an like progesterone or insulin, bpV(pic) induces this character-
additional 30 min, following which autophosphorylation was initi- istic mobility shift, indicating that bpV(pic) activated Xeno-
ated with the addition of 5 mM MnCl2, 1 mM unlabeled ATP, and pus MAP kinase.10 mCi [g-32P]ATP (Amersham, 6000 Ci/mmole). Autophosphoryla-
We have recently reported that insulin causes an acutetion was allowed to proceed at room temperature for an additional
accumulation of PI(3,4,5)P3, the major inducible product40 min before being quenched by SDS sample buffer. The samples
of PI 3-kinase, in Xenopus oocytes and that a PI 3-kinasewere then analyzed by SDS±PAGE followed by autoradiography.
inhibitor, wortamnnin, inhibits the phosphoinositide accu-
mulation and inhibits insulin-induced oocyte maturation
Production of PI(3,4,5)P3 in Intact Oocytes (Liu et al., 1995). We wished to determine whether bpV(pic)
causes a similar accumulation of the phosphoinositide. Oo-
Oocytes were incubated in phosphate-free OR2 (82.50 mM NaCl,
cytes were metabolically labeled with 32P and incubated2.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM Hepes, pH 7.8)
brie¯y with either insulin or bpV(pic). Production ofcontaining 2 mCi/ml [32P]orthophosphate at room temperature for
PI(3,4,5)P3 was analyzed as described under Materials and3 hr. Metabolically labeled oocytes were rinsed several times with
Methods. Figure 3 shows that indeed bpV(pic), like insulin,K/-free OR2 and then incubated for 10 min in the same buffer
containing either 0.5 mM bpV(pic) or 1 mM insulin. Total phospho- causes an acute accumulation of the phosphoinositide, sug-
lipid extraction, TLC separation of phospholipids, deacylation, and gesting that, like insulin, bpV(pic) activates PI 3-kinase in
HPLC analysis of glycerolphosphoinositol phosphates have been the intact oocytes. Furthermore, preincubation of oocytes
previously described (Liu et al., 1995). with increasing concentrations of wortmannin resulted in
a dose-dependent inhibition of bpV(pic)-induced GVBD (Fig.
4), suggesting that bpV(pic)-induced oocyte maturation, like
RESULTS insulin-induced oocyte maturation (Liu et al., 1995), re-
quires a functional PI 3-kinase.
Numerous studies have demonstrated that peroxovana-Several peroxovanadium compounds (Posner et al., 1994)
were tested for their ability to induce Xenopus oocyte matu- date (Lonnroth et al., 1993; Kadota et al., 1987a, 1987b;
Fantus et al., 1989; Heffetz et al., 1990) and the stable perox-ration. Stage VI oocytes were isolated from mature animals
previously primed with PMSG and incubated in K/-free ovanadium compounds (Posner et al., 1994) stimulate auto-
phosphorylation of IR and IGF-1 receptor. We wished toOR2 containing one of the three peroxovanadium com-
pounds of the indicated concentrations. GVBD was scored determine whether the endogenous Xenopus IGF-1 receptor
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FIG. 1. Peroxovanadium compounds induce Xenopus oocyte maturation. (A) Groups of 15±25 oocytes were incubated overnight at 187C
in K/-free OR2 containing each of the three peroxovanadium compounds at the indicated concentrations. GVBD-positive oocytes were
counted and expressed as a percentage of total treated oocytes. Shown is a representative experiment. (B) Groups of 15±25 oocytes were
incubated overnight at 187C in K/-free OR2 containing the indicated concentrations of bpV(pic). GVBD-positive oocytes were counted
and expressed as a percentage of total treated oocytes. Shown are means of duplicate determinants with interdeterminant variations less
than 10%.
functionally mediates bpV(pic)-induced oocyte maturation. kinase by bpV(pic) was severely diminished. As a control,
activation of Xenopus MAP kinase by progesterone re-We reasoned that if bpV(pic)-induced oocyte maturation re-
quires activation of the endogenous IGF-1 receptor, injec- mained largely unchanged by the injection (lanes 4±6). Note
that the shift of XMAPK in bpV(pic)-treated samples (lanestion of a neutralizing anti-IR antibody (17A3) should block
the induction. This monoclonal antibody, which was origi- 7 and 9) was only partial (as compared to the complete shift
in Fig. 2B) because only about 40% of the treated oocytesnally generated against human IR, was inhibitory of both
IR and the closely related IGF-1 receptor by binding to the (samples 7 and 9) were GVBD positive in this particular
experiment (as compared to 100% in Fig. 2B). In contrast,tyrosine kinase domains (Morgan et al., 1986). Furthermore,
17A3 inhibited insulin-induced oocyte maturation when in- none of the 19 oocytes that received 17A3 underwent GVBD
(sample 8).jected into Xenopus oocytes, presumably by blocking the
endogenous IGF-1 receptor (Morgan et al., 1986). Table 1 To con®rm that 17A3 did inhibit autophosphorylation of
Xenopus IGF-1 receptor, we employed an in vitro kinasesummarizes three independent microinjection experi-
ments. Microinjection of 17A3 into stage VI Xenopus oo- assay that has previously been used by many others (Janicot
and Lane, 1989; Hainaut et al., 1991). Xenopus IGF-1 recep-cytes, estimated at 100 nM ®nal concentration in the cyto-
plasm, based on assumptions similar to those previously tor was partially puri®ed by af®nity chromatography on
WGA Sepharose and subjected to autophosphorylationdescribed (Morgan et al., 1986), blocked insulin-induced oo-
cyte maturation, con®rming the earlier report (Morgan et assays (Fig. 6). As shown by many others, preincubation of
the receptor preparation with IGF-1 or insulin resulted inal., 1986). Importantly, microinjection of the same amount
of 17A3 also abolished bpV(pic)-induced oocyte maturation. activation of autophosphorylation of two closely migrating
bands of about 90±100 kDa (arrows). However, the presenceIn contrast, injection of 17A3 had no effect on progesterone-
induced oocyte maturation, indicating that the antibody did of 17A3 monoclonal antibody (lanes 5 and 6), but not non-
speci®c IgG (lane 4), diminished autophosphorylation of thenot affect cell viability or the general cellular apparatus
necessary for undergoing GVBD. Furthermore, injection of receptor.
Although insulin-induced Xenopus oocyte maturationeither phosphate-buffered saline (PBS, Table 1) or nonspe-
ci®c mouse IgG (see below) had no effect. has been a very popular experimental system since its dis-
covery almost two decades ago (El-Etr et al., 1979; MallerTo further establish the speci®city of 17A3 on oocyte
GVBD, we also analyzed the effect of microinjection of the and Koontz, 1981), it has generally been assumed that insu-
lin (or IGF-1) has little signi®cance in mediating gonadotro-antibody on Xenopus MAP kinase activation. Figure 5
shows that following injection of 17A3 (lane 8), but not of pin-induced ovulation in the intact animals (Smith, 1989).
To test this notion more directly, we employed an assaynonspeci®c mouse IgG (lane 7), activation of Xenopus MAP
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FIG. 2. BpV(pic) activates MPF and Xenopus MAP kinase. (A) MPF extracts were prepared from oocytes following overnight incubation
with the various agents. These extracts were separately injected into immature oocytes (34 nl/oocyte). Injected oocytes were incubated
at 187C for 3 hr in OR2 and scored for GVBD. Shown are percentages of injected oocytes that became GVBD-positive following the
incubation (each group had at least 20 oocytes). (B) Ten oocytes each from overnight incubation in OR2 (control, which were GVBD
negative) or overnight incubation in OR2 containing progesterone, insulin, or bpV(pic) (all GVBD positive) were lysed in 100 ml of PBS
lysis buffer. Ten microliters of the clari®ed oocyte lysate (equivalent of one oocyte) were boiled in SDS±sample buffer and analyzed by
SDS±PAGE (12.5% gel) followed by Western blotting with anti-Xenopus MAP kinase antiserum and ECL detection (Amersham). The two
forms of Xenopus MAP kinase are indicated.
similar to that described by Snyder and Schuetz (1973), who
examined the effect of inhibiting steroidgenesis in isolated
ovarian follicles on gonadotropic hormone (in the form of
pituitary extract)-induced oocyte maturation. Isolated oo-
cyte±follicle cell complexes (see Material and Methods)
were incubated with various concentrations of commercial
FIG. 4. Wortmannin inhibits bpV(pic)-induced oocyte matura-
tion. Groups of 10 oocytes were pretreated with the indicated con-
centrations of wortmannin (in OR2) for 10 min at room tempera-
ture. Following the incubation, wortmannin was removed by trans-
ferring the oocytes through two to three successive wells
containing 2 ml of K/-free OR2. The washed oocytes were incu-
bated overnight at 187C with the indicated reagents. GVBD-positiveFIG. 3. BpV(pic) activates PI 3-kinase in intact oocytes. Groups
of 25 oocytes were metabolically labeled with 32P, stimulated with oocytes were counted and expressed as percentage of maximum
response. The maximum response was 100% for progesterone,either bpV(pic) or insulin for 10 min. Production of PI(3,4,5)P3 were
analyzed as described under Materials and Methods. The results 100% for insulin, and 82% for bpV(pic). All the points for bpV(pic)
are means of triplicate determinants. Interdeterminant variationswere expressed as fold of basal production, which was about 1000
cpm. are less than 10% (not shown).
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cle cell complexes is mediated by the receptor present on
the surface of oocytes rather than of the follicle cells. Ami-
noglutethimide phosphate, a potent inhibitor of cyto-
chrome P450 side-chain cleavage enzyme (Behrman et al.,
1970), inhibited hCG-induced GVBD, consistent with the
notion that the commercial hCG-induced GVBD was medi-
ated by the production of progesterone in the follicle cells.
FIG. 5. 17A3 inhibits bpV(pic)-induced Xenopus MAP kinase acti-
vation. Groups of about 20 oocytes either received no injection or DISCUSSION
were injected with 17A3 (cytoplamic concentration estimated at
100 nM) or nonspeci®c mouse IgG (100 nM). Injected oocytes were
We report here that a synthetic peroxovanadium com-incubated at 187C overnight in OR2 (lanes 1±3), OR2 containing
pound bpV(pic) (Posner et al., 1994) induced resumption ofprogesterone (lanes 4±6), or bpV(pic) (lanes 7±9). Following GVBD
meiosis in isolated Xenopus oocytes, as indicated by GVBD.scoring, the oocytes in each group were pooled and lysed. Total
proteins were analyzed by SDS±PAGE followed by Western blot- These results are in agreement with an earlier report by
ting with antibody against Xenopus MAP kinase as in Fig. 2B. Hainaut et al. (1991), which indicated that a high concentra-
tion (10 mM) of vanadate was capable of inducing GVBD in
isolated Xenopus oocytes. In addition, we demonstrated for
the ®rst time that bpV(pic) also mimicked insulin in activat-
ing PI 3-kinase, MPF, and Xenopus MAP kinase in intacthCG. The minimum concentration of hCG required to in-
duce GVBD was determined to be between 1 and 10 IU/ml oocytes.
More importantly, we demonstrated that prior injection of(not shown). Next, we injected 17A3 monoclonal antibody,
or control IgG, directly into the oocytes, and the complexes a neutralizing anti-insulin receptor antibody (17A3) into oo-
cytes rendered them incapable of responding to either insulinwere stimulated with insulin (1 mM) or hCG (10 IU/ml).
Table 2 summarizes three independent experiments which or bpV(pic), but did not affect progesterone-induced oocyte
maturation. These results suggest that the tyrosine kinaseindicate that injecting 17A3 into the oocytes had no effect
on hCG-induced GVBD. In contrast, insulin response was activity of endogenous IGF-1 receptor is required for the cellu-
lar action of peroxovanadium compounds. Consistent withabolished by injection of 17A3, as was the case in the colla-
genase-defolliculated oocytes. We believe, although we can- this notion, we also demonstrated that blocking PI 3-kinase,
a known effector of IR or IGF-1 receptor (Cheatham et al.,not prove, that insulin-induced GVBD in these oocyte±folli-
TABLE 1
Microinjection of Anti-IR Antibody (17A3) Inhibits bpV(pic)-Induced Oocyte Maturation
GVBD
Experiment 1 Experiment 2 Experiment 3
Injection Agonists Number % Number % Number %
No injection Control 0/27 0 0/24 0 0/20 0
Progesterone 28/30 93 14/14 100 24/24 100
Insulin 28/30 93 38/44 86 28/30 93
bpV(pic) 31/31 100 22/26 85 35/35 100
PBS Control 0/20 0 0/20 0 ND
Progesterone 15/16 94 16/16 100
Insulin 30/30 100 24/26 92
bpV(pic) 27/27 100 48/48 100
17A3 Control 0/15 0 0/20 0 0/10 0
Progesterone 16/16 100 19/19 100 10/10 100
Insulin 2/23 9 0/25 0 0/10 0
bpV(pic) 2/30 7 2/30 7 0/10 0
Note. Oocytes were either left uninjected (no injection), or injected with PBS (64 nl/oocyte) or 17A3 (0.3 mg/ml, 64 nl/oocyte). Control
or injected oocytes were incubated in media for 1±2 hr before the addition of the indicated agonists. GVBD were scored following overnight
incubation and expressed both in actual numbers (GVBD positive oocytes/total treated oocytes) and percentages. ND, not done.
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eral groups have recently reported that introducing either
the SH2 domains or an enzymatically inactive form of SH-
PTP2 into cells resulted in inhibition of insulin-induced
mitogenesis, suggesting that the PTPase functions posi-
tively in insulin signaling (Milarski and Saltiel, 1994; Xiao
et al., 1994; Noguchi et al., 1994). On the surface, these
results seem to contradict our data which suggest that in-
hibiting an PTPase(s) results in activation of the IGF-1 re-
ceptor pathway. Several explanations may help to reconcile
these differences. First, it is possible that the Xenopus ho-
molog of SH-PTP2 or XSH-PTP2 (Tang et al., 1995), which
is present in immature Xenopus oocytes (C. Cummings, R.
Freeman, B. Neel, and X. J. Liu, unpublished data), may not
be inhibited by the concentrations of bpV(pic) used here.
Our attempt to assay for in vitro PTPase activity in anti-
FIG. 6. 17A3 inhibits autophosphorylation of Xenopus IGF-1 re- XSH-PTP2 immunoprecipitates has been inconclusive (not
ceptor. WGA-puri®ed Xenopus receptor was incubated in buffer shown). Therefore we have been unable to address this pos-
(lanes 1±3) or buffer containing nonspeci®c mouse IgG (lane 4) or sibility directly. Second, XSH-PTP2 may not play any role
17A3 (lanes 5 and 6). Activation by insulin (lanes 3±6) or IGF-1
in insulin-induced oocyte maturation, which is mediated(lane 2) was carried out followed by autophosphorylation in the
through endogenous IGF-1 receptor (Cicirelli et al., 1990;presence of [g-32P]ATP. Autophosphorylation of Xenopus IGF-1 re-
Chuang et al., 1993; Hainaut et al., 1991) rather than IR asceptor was analyzed by SDS±PAGE and autoradiography. Arrows
in the case of the other studies (Milarski and Saltiel, 1994;indicate the previously identi®ed Xenopus IGF-1 receptor b subunit
Xiao et al., 1994; Noguchi et al., 1994). In either case, a(Janicot and Lane, 1989; Hainaut et al., 1991).
different PTPase is postulated to be responsible for nega-
tively regulating Xenopus IGF-1 receptor and therefore is
the target of bpV(pic). A third possibility is that XSH-PTP2
is the dominant inhibitor of IR or IGF-1 receptor and hence1994; Chung et al., 1994; Liu et al., 1995), with wortmannin
also inhibited bpV(pic)-induced oocyte maturation. the target of bpV(pic). In this case, insulin-induced binding
of tyrosine-phosphorylated IRS-1 to SH-PTP2 (KuhneÂ et al.,Given that bpV(pic) is a potent PTPase inhibitor (Posner
et al., 1994), our data suggest that a yet unidenti®ed
PTPase(s) functions upstream of Xenopus IGF-1 receptor as
a negative regulator. Hence inhibition of such a PTPase(s)
TABLE 2results in spontaneous activation of the receptor and recep-
17A3 Does Not Affect Gonadotropin-Induced Xenopustor-mediated oocyte maturation. At the present time, the
Oocyte Maturationspeci®city of bpV(pic) is unclear and hence the precise tar-
get(s) of this compound in Xenopus oocytes remains to be IgG 17A3 No injection
determined. It is possible, or even likely, that bpV(pic) in- (%) (%) (%)
hibits multiple PTPases in Xenopus oocytes. However, inhi-
Experiment 1bition of any phosphatases that lie downstream of Xenopus
hCG 60 52 66IGF-1 receptor is apparently not suf®cient to induce GVBD,
AGP / hCG ND ND 7since bpV(pic) was unable to cause GVBD if 17A3 was pres-
No hormone 0 0 0ent in the oocytes. Furthermore, we suggest the existence
Experiment 2of at least some selectivity of bpV(pic) since activation of
hCG 81 81 88MPF, which requires a Xenopus cdc25 (a PTPase)-dependent
No hormone 5 6 10dephosphorylation of MPF on phosphotyrosine (Jessus and
Beach, 1992), is not inhibited (Fig. 2A). Experiment 3
To date, the best known PTPase that has been implicated hCG 77 76 85
in insulin receptor signaling is a Src homology 2 (SH2) do- Insulin 77 0 91
No hormone 0 0 0main-containing PTPase, SH-PTP2 or Syp (Freeman et al.,
1992; Feng et al., 1993). SH-PTP2 is widely expressed both
Note. Manually isolated oocyte±follicle cell complexes were in-during embryogenesis and in adult animals. Insulin stimu-
jected with nonspeci®c mouse IgG or 17A3 or left uninfected. Groupslates tyrosine phosphorylation of insulin receptor substrate-
of 20±30 so treated complexes were incubated in buffer (no hormone)
1 (IRS-1) (Sun et al., 1991) and binding of the tyrosine phos- or buffer containing 10 IU/ml hCG or 1 mM insulin. GVBD were
phorylated IRS-1 to SH-PTP2 (KuhneÂ et al., 1993). This scored following overnight incubation at 187C and expressed as a
binding is mediated by a speci®c IRS-1 tyrosine phosphory- percentage of total treated oocyte±follicle cell complexes. Aminoglu-
lation site (Tyr-1172) (Sun et al., 1991) and the SH2 domains tehimide phosphate (AGP) was dissolved in DMSO as 0.7 M stock
and added together with hCG to a ®nal concentration of 0.75 mM.of the PTPase (Songyang et al., 1993; Sun et al., 1993). Sev-
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maturation of Xenopus oocytes. Proc. Natl. Acad. Sci. USA 90,1993) may function to sequester SH-PTP2 and hence allevi-
5172±5175.ate the inhibition. Introducing either the SH2 domains or
Chung, J., Grammer, T. C., Lemon, K. P., Kazlouskas, A., andan enzymatically inactive SH-PTP2 (the latter may be func-
Blenis, J. (1994). PDGF- and insulin-dependent pp70S6K activationtionally equivalent to SH-PTP2 SH2 domains) (Milarski and
mediated by phosphatidylinositol-3-OH kinase. Nature 370, 71±Saltiel, 1994; Xiao et al., 1994; Noguchi et al., 1994) into
75.
cells may disrupt this insulin-induced binding of IRS-1 to Cicirelli, M. F., Tonks, N. K., Diltz, C. D., Weiel, J. E., Fischer,
SH-PTP2 and hence the PTPase sequestration. The uncou- E. H., and Krebs, E. G. (1990). Microinjection of a protein-tyro-
pling of ligand binding from this PTPase sequestration may sine-phosphatase inhibits insulin action in Xenopus oocytes.
prevent full activation of the receptor and thus receptor- Proc. Natl. Acad. Sci. USA 87, 5514±5518.
mediated cellular response, such as oocyte GVBD. Deshpande, A. K., and Kung, H.-F. (1987). Insulin induction of Xen-
opus laevis oocyte maturation is inhibited by monoclonal anti-It is worth noting that, unlike most other receptor protein
body against p21 ras proteins. Mol. Cell. Biol. 7, 1283±1288.tyrosine kinases which are monomeric proteins requiring
Dumont, J. N. (1971). Oogenesis in Xenopus laevis (Daudin). J.ligand-induced dimerization for autophosphorylation (via a
Morphol. 136, 153±180.transphosphorylation mechanism) and receptor activation
El-Etr, M., Schorderet-Slatkine, S., and Baulieu, E. E. (1979). Meiotic(Heldin, 1995), IR (or IGF-1R) has two b subunits which
maturation in Xenopus laevis oocytes initiated by insulin. Sci-contain intrinsic protein tyrosine kinase activity (Kahn et
ence 205, 1397±1399.
al., 1993). Therefore it is possible that IR (or IGF-1R) could Fantus, I. G., Kadota, S., Deragon, G., Foster, B., and Posner, B.
undergo at least a low level of autophosphorylation in a (1989). Pervanadate (peroxide of vanadate) mimics insulin action
ligand-independent fashion. This low level of autophos- in rat addipocytes via activation of insulin receptor. Biochemistry
phorylation may be reversed physiologically by the pro- 28, 8864±8871.
posed dominant PTPase. Whereas if the PTPase is inhibited Feng, G.-S., Hui, C.-C., and Pawson, T. (1993). An SH2-containing
phosphotyrosine phosphatase broadly expressed during mouse[as suggested here by bpV(pic)], this ligand-independent re-
embryogenesis is a target of receptor and transforming tyrosineceptor autophosphorylation may lead to full activation. The
kinases. Science 259, 1607±1611.unique structure of IR (or IGF-1R) may therefore explain
Freeman, R. M., Jr., Plutzky, J., and Neel, B. G. (1992). Identi®cationthe particularly potent ``insulin mimetic'' effect of vana-
of a human src homology 2-containing protein tyrosine phospha-dium and peroxovanadium compounds.
tase: A putative homolog of Drosophilar corkscrew. Proc. Natl.
Acad. Sci. USA 89, 11239±11243.
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